Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

4.7K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging Approaches for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease: The Application of Nanomedicines.

International journal of nanomedicine·2026
Same author

Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid.

Journal of hepatology·2026
Same author

Predictive models for dysphagia in older adults: a systematic review and meta-analysis.

Frontiers in public health·2026
Same author

8-Chloro-adenosine inhibits breast cancer progression by inducing ferroptosis via the ADAR1/miR-101-3p/SLC7A11 axis.

Cancer cell international·2026
Same author

Interpretable machine learning model for predicting covert hepatic encephalopathy in patients with cirrhosis: a multicenter study.

Frontiers in medicine·2025
Same author

Dual-wavelength UV photofunctionalization of 3D-printed Ti6Al4V porous bone implant enhances osseointegration via adhesion-cytoskeleton-nuclear mechanotransduction.

Materials today. Bio·2025
Same journal

Jejunal Leiomyosarcoma in a Young Adult: Distinguishing from Gastrointestinal Stromal Tumor through Radiographic, Histologic, and Epidemiologic Analysis - A Case Report.

Gastrointestinal tumors·2024
Same journal

The Incidence and Outcomes of Venous Thromboembolisms in Patients Admitted with Different Gastrointestinal Malignancies.

Gastrointestinal tumors·2024
Same journal

Current Surgical Methods in Local Rectal Excision.

Gastrointestinal tumors·2024
Same journal

A Retrospective Study of Clinical Outcomes for Patients with Esophageal Cancer Who Were Treated with Radiotherapy Alone.

Gastrointestinal tumors·2024
Same journal

Investigation of Novel Urinary Biomarkers in Hepatocellular Carcinoma Risk in a Predominantly African American Population: A Case-Control Study.

Gastrointestinal tumors·2024
Same journal

Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers.

Gastrointestinal tumors·2023
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K

Hepatocellular Carcinoma: Basic and Transitional Research.

Chuan Yin1, Wei-Fen Xie1

  • 1Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai, PR China.

Gastrointestinal Tumors
|December 18, 2015
PubMed
Summary
This summary is machine-generated.

Novel therapies for advanced hepatocellular carcinoma (HCC) are emerging, including molecular-targeted drugs, cancer stem cell (CSC)-based treatments, and differentiation therapies. These approaches aim to improve outcomes for patients with advanced HCC where standard treatments are insufficient.

Keywords:
Cancer stem cellsDifferentiationHepatocellular carcinomaMolecular-targeted therapiesSignaling pathways

More Related Videos

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

2.8K
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

37.4K

Related Experiment Videos

Last Updated: Mar 28, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

2.8K
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

37.4K

Area of Science:

  • Hepatocellular carcinoma (HCC) research
  • Molecular oncology
  • Therapeutic development

Background:

  • Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
  • Treatment efficacy for HCC is highly dependent on the disease stage.
  • Advanced HCC lacks standardized effective treatment regimens.

Purpose of the Study:

  • To review novel therapeutic agents under development for hepatocellular carcinoma (HCC).
  • To discuss molecular-targeted therapies, cancer stem cell (CSC)-based therapies, and differentiation therapies for HCC.
  • To highlight advancements in understanding HCC molecular pathogenesis.

Main Methods:

  • Review of current literature on novel HCC therapeutic agents.
  • Analysis of molecular-targeted therapies including tyrosine kinase inhibitors (TKIs), monoclonal antibodies, and enzyme inhibitors.
  • Examination of cancer stem cell (CSC)-based strategies and differentiation therapy approaches.

Main Results:

  • Molecular-targeted therapies, such as sorafenib (a TKI), are in clinical trials for HCC.
  • Other targeted agents like erlotinib, linifanib, and brivanib are under investigation.
  • Early-stage CSC-based therapies and differentiation therapies show promise, often requiring combination with conventional treatments.

Conclusions:

  • Advances in understanding HCC molecular mechanisms are driving the development of new therapies.
  • Molecular-targeted therapies, CSC-based treatments, and differentiation therapies represent key areas of novel HCC drug development.
  • Combination strategies involving CSC-targeted therapy and differentiation agents hold potential for improved HCC treatment outcomes.